InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the full record of transactions filed by McClellan William D. Jr., Director. Director active across 3 companies, notably Apollo Endosurgery, Inc.. In total, 10 filings have been published. History available since 17 June 2021. The latest transaction was filed on 7 June 2023 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Declarations10 total
6,017 sharesClass A common stockSEC:0000899243-23-019534:0
5,000 sharesClass A common stockSEC:0001209191-23-043997:0
106 shares@ US$93.6143.3% of flowClass A common stockSEC:0001209191-23-035833:0
39,249 sharesCommon StockSEC:0001251769-23-000026:0
14,224 shares0Common StockSEC:0001251769-22-000056:0
287 shares@ US$34.7676.7% of flowClass A common stockSEC:0001209191-22-035412:0
59 shares@ US$27.326.6% of flowClass A common stockSEC:0001209191-22-001625
59 shares@ US$27.3211.7% of flowClass A common stockSEC:0001209191-22-001625:0
3,888 shares0Common StockSEC:0001251769-21-000085
3,888 shares0Common StockSEC:0001251769-21-000085:0
10 of 10 declarations
About McClellan William D. Jr.
William D. McClellan Jr. is a Board Member at Apollo Endosurgery, Inc. and REATA PHARMACEUTICALS INC. He has extensive experience in the medical devices and biopharmaceutical sectors. As a Board Member, he oversees growth and innovation strategies for these companies.
